U.S. Department of Health and Human Services
 

 Contact Info

 
Tel: 301-402-8291
Email: lescheke@extra.niddk.nih.gov
 

 Select Experience

 
  • Clinical AssociateDevelopmental Endocrinology Branch, NICHD, NIH1995-2003
  • Pediatric Endocrinology FellowshipDevelopmental Endocrinology Branch, NICHD, NIH1992-1995
  • Pediatrics ResidencyMedical Center of Delaware1988-1991
  • M.D.The George Washington University School of Medicine1988

Ellen Leschek, M.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities and Activities

As program director for the Type 1 Diabetes TrialNet, I oversee a large clinical trial network of international studies that address prevention of and early intervention in type 1 diabetes, as well as the natural history and genetics of this disease.  As program director for the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) follow-up study, I oversee the administrative aspects of the DCCT/EDIC Coordinating Center and the DCCT/EDIC Administrative Core and serve as the executive secretary for the DCCT/EDIC Observational Study Monitoring Board.  As the project officer for the Diet and Exercise in the Prevention and Treatment of Diabetes grant portfolio, I oversee all aspects of a number of grants focusing on the roles of diet and exercise in the prevention and treatment of diabetes.

My responsibilities also include membership on the NIH Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt-Jakob Disease.  In this capacity, I review all deaths occurring in members of the cohort treated with cadaverine hGH through the National Hormone and Pituitary program.  I serve as a member of the NIDDK Clinical Studies Working Group and as chair of the DEM Clinical Working Group.  I also serve as a special volunteer for the Pediatric Endocrinology Clinic, evaluating and treating patients and training NICHD’s Pediatric Endocrinology Fellows.

​Research Programs

Clinical Research in Type 1 Diabetes
This program supports clinical research that addresses the determinants, etiology, progression, prevention, and treatment of type 1 diabetes in children and adults

Genetic Metabolic Disease
This program supports basic and clinical research that addresses the pathophysiology and treatment of inborn errors of metabolism and rare genetic metabolic diseases, including lipodystrophy, maturity onset diabetes of the young (MODY), Primary Hyperoxaluria, systemic amyloidosis and porphyria.

Current Committee Memberships

  • NIH Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt-Jakob DiseaseMember
  • NIDDK Clinical Studies Working GroupMember